Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nevro Corp
(NY:
NVRO
)
4.520
+0.160 (+3.67%)
Official Closing Price
Updated: 7:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nevro Corp
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 12, 2024
Via
Benzinga
Why Medical Device Firm Nevro Stock Is Trading Higher On Tuesday
November 12, 2024
Nevro stock rises as it gains CE Mark for its HFX iQ SCS system, the first with AI-based personalized pain relief. 2024 revenue outlook raised amid positive earnings.
Via
Benzinga
Peeling Back The Layers: Exploring Nevro Through Analyst Insights
November 12, 2024
Via
Benzinga
Earnings Scheduled For November 11, 2024
November 11, 2024
Via
Benzinga
A Look Ahead: Nevro's Earnings Forecast
November 08, 2024
Via
Benzinga
Breaking Down Nevro: 10 Analysts Share Their Views
October 01, 2024
Via
Benzinga
Assessing Nevro: Insights From 9 Financial Analysts
August 08, 2024
Via
Benzinga
Evaluating Nevro: Insights From 8 Financial Analysts
August 07, 2024
Via
Benzinga
Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
August 07, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 07, 2024
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!
Via
InvestorPlace
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
August 07, 2024
Via
Benzinga
Beyond The Numbers: 6 Analysts Discuss Nevro Stock
July 15, 2024
Via
Benzinga
Assessing Nevro: Insights From 9 Financial Analysts
May 08, 2024
Via
Benzinga
NVRO Stock Earnings: Nevro Beats EPS, Misses Revenue for Q2 2024
August 06, 2024
NVRO stock results show that Nevro beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
NVRO stock results show that Nevro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
April 09, 2024
Via
AB Newswire
Where Nevro Stands With Analysts
April 03, 2024
Via
Benzinga
Why Nevro Stock Lagged the Market on Thursday
February 22, 2024
Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.
Via
The Motley Fool
Analyst Scoreboard: 4 Ratings For Nevro
February 22, 2024
Via
Benzinga
Nevro: Q4 Earnings Insights
February 21, 2024
Via
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
What Analysts Are Saying About Nevro Stock
January 12, 2024
Via
Benzinga
Forecasting The Future: 6 Analyst Projections For Nevro
December 21, 2023
Via
Benzinga
Where Nevro Stands With Analysts
December 01, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Nevro
November 02, 2023
Via
Benzinga
Earnings Preview For Nevro
October 31, 2023
Via
Benzinga
What 21 Analyst Ratings Have To Say About Nevro
August 21, 2023
Via
Benzinga
Expert Ratings for Nevro
August 03, 2023
Via
Benzinga
Why Shares of Nevro Are Down Wednesday
August 02, 2023
The medical device maker saw increased revenue, but earnings lagged estimates.
Via
The Motley Fool
Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street Estimates
August 02, 2023
Pain management company Nevro Corp (NASDAQ: NVRO) reported Q2 FY23 revenue of $108.8 million, up 4% Y/Y, missing the management guidance of $110 million-$112 million and
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.